Moderna, Inc. (MRNA)
Last Price$35.55.3%
Market Cap$13.7B
DCF value
N/A
Overvalued (DCF value)
(100.0%)
Discount Rate
10.8%
Long-Term Growth Rate
3.0%
Stock quality
6/10
Good
MRNA DCF Model
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
MRNA DCF Value
Crunching data... Almost there!
MRNA DCF Financials
Crunching data... Almost there!
MRNA DCF sensitivity
Crunching data... Almost there!
Explore more intrinsic value tools hub for MRNA
Margin of safety
Peter Lynch charts
Ben Graham Fair Value
Earnings Power Value
Relative Value
Earnings growth model
Discount rate
Peter Lynch Fair Value
Intrinsic Value
Reverse DCF
FAQ
What is Moderna, Inc. DCF (discounted cash flow) valuation?
As of Feb 21, 2025, Moderna, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by (100.0%) compared to its current price of around $35.5, using a WACC of 10.8% and growth rates of 3.0%.
What is Moderna, Inc. WACC?
As of Feb 21, 2025, Moderna, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 10.8%.
What is Moderna, Inc. Enterprise Value?
As of Feb 21, 2025, Moderna, Inc.'s Enterprise Value (EV) is approximately $0.0. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.